Headline News2011 North American Cystic Fibrosis Conference in Anaheim, CA
Vertex Begins Clinical Trial to Evaluate Combination of VX-770 and VX-809 Targeting Most Common Mutation in CF Transitioning to Adult Care Events SAVE THE DATE: Cystic Fibrosis: A Collaborative Forum on 9/17 or 9/24 (Final Date TBD) | 
